Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | MTHFD2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | CLSPN | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | ENAM | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | SRSF1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | FAM19A4 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | ADAD2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | PLCG1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | ST20-MTHFS | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | FRMD1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |